Which types of prostate cancer is Nubeqa (darolutamide) indicated to treat in adult men?

Nubeqa (darolutamide) is indicated for adult men with non-metastatic castration-resistant prostate cancer at high risk of developing metastatic disease, or metastatic hormone-sensitive prostate cancer in combination with androgen deprivation therapy or with docetaxel.